International Stem Cell Co. (OTCMKTS:ISCO) Sees Significant Increase in Short Interest

International Stem Cell Co. (OTCMKTS:ISCO) was the recipient of a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 1,500 shares, an increase of 400.0% from the December 31st total of 300 shares. Based on an average daily trading volume, of 22,400 shares, the days-to-cover ratio is currently 0.1 days.

International Stem Cell Stock Up 16.7 %

Shares of International Stem Cell stock traded up $0.02 during midday trading on Tuesday, hitting $0.11. The company had a trading volume of 2,401 shares, compared to its average volume of 3,108. The stock has a market cap of $840,000.00, a price-to-earnings ratio of -1.31 and a beta of 0.21. International Stem Cell has a 12-month low of $0.05 and a 12-month high of $0.20. The company has a fifty day simple moving average of $0.10 and a 200 day simple moving average of $0.08.

International Stem Cell Company Profile

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.